We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$302B
AUM Growth
+$34.6B
Cap. Flow
+$23B
Cap. Flow %
7.61%
Top 10 Hldgs %
17.01%
Holding
3,993
New
281
Increased
2,296
Reduced
1,151
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Financials 13.67%
3 Healthcare 11.47%
4 Consumer Discretionary 11.19%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALIM
3726
DELISTED
Alimera Sciences
ALIM
$15K ﹤0.01%
+1,033
New +$14.5K
GNCA
3727
DELISTED
Genocea Biosciences, Inc.
GNCA
$14K ﹤0.01%
+1,979
New +$14.8K
RGLS
3728
DELISTED
Regulus Therapeutics
RGLS
$13K ﹤0.01%
+169
New +$14K
WYY icon
3729
WidePoint Corp
WYY
$97.4M
$13K ﹤0.01%
+2,450
New +$13.2K
MTNB icon
3730
Matinas BioPharma
MTNB
$1.91M
$11K ﹤0.01%
+516
New +$14.9K
TMBR
3731
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$11K ﹤0.01%
+3
New +$10.1K
NAVB
3732
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
+2,403
New +$12.6K
CBK
3733
DELISTED
Christopher & Banks Corporation
CBK
$11K ﹤0.01%
+11,229
New +$11.3K
GMO
3734
DELISTED
General Moly, Inc.
GMO
$10K ﹤0.01%
+23,398
New +$9.25K
MBOT icon
3735
Microbot Medical
MBOT
$112M
$9K ﹤0.01%
+828
New +$10.1K
TRAW icon
3736
Traws Pharma
TRAW
$7.34M
$9K ﹤0.01%
+4
New +$11.6K
QCLS
3737
Q/C Technologies Inc
QCLS
$19.7M
0
VRML
3738
DELISTED
Vermillion, Inc.
VRML
$9K ﹤0.01%
+11,774
New +$13.2K
TOVX icon
3739
Theriva Biologics
TOVX
$10.1M
$8K ﹤0.01%
+4
New +$9.18K
UAMY icon
3740
United States Antimony
UAMY
$728M
$8K ﹤0.01%
+15,896
New +$5.27K
GPUS
3741
Hyperscale Data Inc
GPUS
$52.9M
0
HGT
3742
DELISTED
Hugoton Royalty Trust
HGT
$8K ﹤0.01%
+11,797
New +$8.32K
CATX icon
3743
Perspective Therapeutics
CATX
$327M
$7K ﹤0.01%
+1,625
New +$7.52K
XPL icon
3744
Solitario Resources
XPL
$66.3M
$7K ﹤0.01%
+17,203
New +$7.52K
IPAS
3745
DELISTED
Ipass Inc Common Stock
IPAS
$7K ﹤0.01%
+1,952
New +$7.22K
KPRX icon
3746
Kiora Pharmaceuticals
KPRX
$11.4M
$6K ﹤0.01%
+2
New +$5.64K
EGLT
3747
DELISTED
Egalet Corporation
EGLT
$6K ﹤0.01%
+13,596
New +$7.57K
AGIG
3748
Abundia Global Impact Group
AGIG
$40.5M
$5K ﹤0.01%
+121
New +$3.87K
WWR icon
3749
Westwater Resources
WWR
$49.7M
$5K ﹤0.01%
+249
New +$6K
AUMN
3750
DELISTED
Golden Minerals Company
AUMN
$5K ﹤0.01%
+607
New +$6.02K

Similar funds

Invesco's Q2 2018 Portfolio in Review

As of Q2 2018, Invesco held 3,993 positions worth $302B, up 13% from $268B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco deployed $23B of net new capital in Q2 2018, opening 281 new positions and adding to 2,296 existing holdings. Its largest new stake was Invesco Short Term Treasury ETF: 4,268,300 shares worth $453M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vodafone, an estimated $205M trimmed.

  • Invesco's largest Q2 2018 buy was Invesco Short Term Treasury ETF: 4,268,300 shares worth $453M.
  • Invesco added most to Amazon in Q2 2018, an estimated $389M increase.
  • Invesco's biggest Q2 2018 reduction was Vodafone, cutting an estimated $205M.
  • Invesco fully exited PowerShares Treasury Collateral Portfolio in Q2 2018, selling an estimated $451M.
  • Invesco's ten largest holdings make up 17% of its $302B portfolio in Q2 2018.
  • Invesco opened 281 new positions and closed 120 in Q2 2018.
  • Invesco's portfolio value rose 13% quarter-over-quarter to $302B.

Based on Invesco's 13F filing for Q2 2018, filed 14 Aug 2018.